Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

NCT02743923 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

203

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small Cell Lung

Interventions

DRUG: carboplatin
DRUG: paclitaxel
DRUG: Bevacizumab
DRUG: Pemetrexed
DRUG: cisplatin

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]